🦷 Antibiotics for dental infections: In a retrospective cohort study, treatment failure was higher with clindamycin vs amox/clav and with cefdinir vs other studied cephalosporins.
#IDXposts
buff.ly/0cAkGoh
Wishing a very, Happy Diwali to our community! 🪔
#FestivalOfLights #Diwali2026 #Inclusivity #IDTwitter #TwitteRx
🍄 Mucormycosis: early recognition matters. This NEJM review covers diagnostics, LamB dosing and other treatment options, surgical management, and reversal of host risk factors.
📖 buff.ly/3VUXHSD
#IDXposts
Unexplained INR elevation on cefazolin? A case report highlights rare cefazolin-associated coagulopathy during MSSA bacteremia treatment, with improvement after vitamin K and a switch to oxacillin.
buff.ly/qdGx8rG
#IDXposts
Honoring Native American Heritage Month 🙏🏽
This month, we recognize and celebrate the diverse cultures, histories, traditions, and enduring contributions of Native American and Indigenous peoples.
We honor the resilience of Indigenous communities, acknowledge the importance of cultural preservation and sovereignty, and recognize the many ways Indigenous peoples continue to shape our communities and our future.
May this month inspire us to listen, learn, and amplify Indigenous voices—not just in November, but throughout the year.
#NativeAmericanHeritageMonth #IndigenousVoices #CulturalAwareness #HealthEquity #DiversityAndInclusion
Clinical Infectious Diseases 📖 published a state-of-the-art review on the diagnosis and management of septic arthritis🦵💪🦶
They highlight that infections of certain joints may require different empiric treatment, along with other risk factors🥛💉🐱
🔗academic.oup.com/cid/article…
Curious about beta-lactam combination therapy for enterococcal bacteremia and endovascular infections? Check out this new narrative review: journals.sagepub.com/doi/10.…
Congratulations to the ACCP ID PRN members who authored this paper!
#IDXposts #Endocarditis #Enterococcus
The CDC has updated its Antimicrobial-Resistant Threats report, including adjusting the format to a website: arpsp.cdc.gov/artr
C. auris, CRAB, CRE, and drug-resistant Neisseria gonorrhoeae are highlighted as urgent threats 🚨
ICYMI, the FDA approved the first antisense oligonucleotide, bepirovirsen (Hibsago), for treatment of chronic hepatitis B last week. It's given with existing therapy for 24 weeks and ⬆️ functional cure rates in the B-Well trials.
Read more here: fda.gov/news-events/press-an…
#IDXposts
Missed #IDWeek2026? Catch up with an overview of highlights⭐ from the Chair & Vice-chair of this year's conference🤝, and detailed daily news‼️
Highlights 🔗: buff.ly/CCVL42X
Daily news 🔗: buff.ly/gVI0Q0B
What was your favorite takeaway from #IDWeek26? 🤔 Tell us in the comments! 📝
Friends attending @IDWeekmtg, reminder to join us Friday evening at Calico for a pharmacist & friends gathering! 🥳🤓
For those attending @IDWeekmtg, reminder to please join us Friday, October 23rd, for a pharmacists and friends meet up! See flyer for details.
#IDXPosts #IDWeek2026
Final day at #ACCPAM26‼️ We hope you've enjoyed the learning📒 & networking 🤝 Safe travels! 🛫
Save the dates 📢
1️⃣ 2027 @ACCP Global Conference🌍
🗓️ October 16-19, 2027
🏩 New York Hilton Midtown, New York, NY
2️⃣ 2027 ACCP Call for Abstracts
🔗 buff.ly/pDLaLxU
Key🔑takeaways:
1⃣ Older👴🧓adults w/ reduced renal🫘 fxn: TMP/SMX for UTI is associated with⬆️hospitalization🏥(for AKI) & death☠️compared to nitrofurantoin
2⃣ Non-abx prophylaxis for recurrent UTI: cranberry & vaginal estrogen - highest grade rec
🔗pubmed.ncbi.nlm.nih.gov/4090…
Day3️⃣ at #ACCPAM26, 10/19 (Mon)‼️
Learn about updates in UTI🫘 management in ambulatory care🏡 and older adults 🧓
🕑 1.45-3.15pm
🏩 Salt Palace Convention Center - Ballroom J
🔗 buff.ly/Ozq2TRS
#IDXPosts
🎀 October is Breast Cancer Awareness Month.
As healthcare professionals, let’s promote awareness, support prevention efforts, & empower patients to make informed decisions!
📷: Charleston International Airport
#BreastCancerAwarenessMonth #ClinicalPharmacy #WearPink
Amazing🌟session🎙️by @accpinfdprn members at #ACCPAM26 by Alireza Hayatshahi, @amykangIDpharm, Elias Chahine👏
Day 2️⃣ at #ACCPAM26, 10/18 (Sun)‼️
@accpinfdprn proudly presents our annual ID🦠 focus session- Guideline Refresh: Navigating Updates in UTI🫘 and CAP🫁 Management
🕑 2.15-3.45pm
🏩 Salt Palace Convention Center - Ballroom E
🔗 buff.ly/sF5WtDB
#IDXPosts
Key 🔑takeaways (cont'd):
3⃣ Abx < 5 days not for CAP🫁caused by S. aureus, P. aeruginosa & Legionella
4⃣ Corticosteroids reserved for severe CAP🫁
5⃣ CAP🫁: drop macrolide once Legionella is ruled out and patient is stable🏥
Key 🔑takeaways (cont'd):
6⃣ Useful resource: ESCMID clinical guidelines on the evaluation and management of a reported antibiotic 💊💉allergy👩⚕️👨⚕️
🔗pubmed.ncbi.nlm.nih.gov/4170…









